Diagnostics company providing answers for clinicians diagnosing, treating and monitoring challenging diseases. The company is built on an ultra-sensitive SERS optical reporter platform technology leveraging novel dyes. Our team’s expertise in research and product development combined with commercial experience fuels our ability to provide meaningful solutions impacting standard of care starting with PanCystPro, a regulatory CLIA-certified assay.